CoMMiTMenT

Combined Molecular Microscopy for Therapy and Personalized Medication in Rare Anaemias Treatments


Description

The aim of CoMMiTMenT is the development of combined imaging technologies based on optofluidic microscopy (OMiCS) and scanning ion conductance microscopy (SCIM), the so-called µCOSMOS, a multi-modular device, which will allow the exploration, diagnosis and development of therapeutic interventions for several rare anaemias. For some of the rare anaemias, CoMMiTMenT will provide an initial proof-of-principle, whereas for others, personalised medical interventions should become available and will be tested in clinical practice within the project. CoMMiTMenT will ensure an effective therapy with diminished undesirable adverse effects, largely replacing splenectomy, and will thus contribute to the goal of the International Rare Diseases Research Consortium (IRDiRC) to deliver novel diagnostic modalities and 200 new therapies for rare diseases by 2020.

Coordinator
Dr Lars Kästner
Universität des Saarlandes (USAAR)
Phone: +49 6841 1626149
Email
Programme
FP7
Duration
60 months (October 2013 - September 2018)
Project funding
€ 5,999,982.25
Project partners
9
About Eurice

Eurice offers knowledge-based consultancy services in project and innovation management.

Eurice Head Office
Heinrich-Hertz-Allee 1
66386 St. Ingbert
Germany
Phone: +49 6894 388130
Email
Eurice Berlin
Alt-Reinickendorf 25
13407 Berlin
Germany
Phone: +49 30 374415840
Email